BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 27118874)

  • 1. Is Renal Impairment an Anticipated COPD Comorbidity?
    AbdelHalim HA; AboElNaga HH
    Respir Care; 2016 Sep; 61(9):1201-6. PubMed ID: 27118874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Chronic renal failure: a neglected comorbidity of COPD.
    Incalzi RA; Corsonello A; Pedone C; Battaglia S; Paglino G; Bellia V;
    Chest; 2010 Apr; 137(4):831-7. PubMed ID: 19903974
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevalence of chronic kidney diseases in patients with chronic obstructive pulmonary disease: assessment based on glomerular filtration rate estimated from creatinine and cystatin C levels.
    Yoshizawa T; Okada K; Furuichi S; Ishiguro T; Yoshizawa A; Akahoshi T; Gon Y; Akashiba T; Hosokawa Y; Hashimoto S
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1283-9. PubMed ID: 26185434
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Is insufficient pulmonary air support the cause of dysphonia in chronic obstructive pulmonary disease?
    Hassan MM; Hussein MT; Emam AM; Rashad UM; Rezk I; Awad AH
    Auris Nasus Larynx; 2018 Aug; 45(4):807-814. PubMed ID: 29325856
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What is the impact of different spirometric criteria on the prevalence of spirometrically defined COPD and its comorbidities? Results from the population-based KORA study.
    Karrasch S; Brüske I; Smith MP; Thorand B; Huth C; Ladwig KH; Kronenberg F; Heinrich J; Holle R; Peters A; Schulz H
    Int J Chron Obstruct Pulmon Dis; 2016; 11():1881-94. PubMed ID: 27574413
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Detection of COPD in a high-risk population: should the diagnostic work-up include bronchodilator reversibility testing?
    Kjeldgaard P; Dahl R; Løkke A; Ulrik CS
    Int J Chron Obstruct Pulmon Dis; 2015; 10():407-14. PubMed ID: 25759573
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Diagnosis of chronic obstructive pulmonary disease earlier than current Global Initiative for Obstructive Lung Disease guidelines using a feasible spirometry parameter (maximal-mid expiratory flow/forced vital capacity).
    Mirsadraee M; Boskabady MH; Attaran D
    Chron Respir Dis; 2013; 10(4):191-6. PubMed ID: 24177680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Hand grip strength is associated with forced expiratory volume in 1 second among subjects with COPD: report from a population-based cohort study.
    Strandkvist VJ; Backman H; Röding J; Stridsman C; Lindberg A
    Int J Chron Obstruct Pulmon Dis; 2016; 11():2527-2534. PubMed ID: 27785009
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Increased risk of exacerbation and hospitalization in subjects with an overlap phenotype: COPD-asthma.
    Menezes AMB; Montes de Oca M; Pérez-Padilla R; Nadeau G; Wehrmeister FC; Lopez-Varela MV; Muiño A; Jardim JRB; Valdivia G; Tálamo C;
    Chest; 2014 Feb; 145(2):297-304. PubMed ID: 24114498
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of ADAMTS-13 on concealed chronic renal failure in COPD patients.
    Zeng M; Chen Q; Liang W; He W; Zheng H; Huang C
    Int J Chron Obstruct Pulmon Dis; 2017; 12():3495-3501. PubMed ID: 29255356
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Peak expiratory flow rate as a surrogate for forced expiratory volume in 1 second in COPD severity classification in Thailand.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C; Bumroongkit C; Deesomchok A; Theerakittikul T; Limsukon A
    Int J Chron Obstruct Pulmon Dis; 2015; 10():1213-8. PubMed ID: 26150713
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chronic obstructive pulmonary disease in patients with end-stage kidney disease on hemodialysis.
    Plesner LL; Warming PE; Nielsen TL; Dalsgaard M; Schou M; Høst U; Rydahl C; Brandi L; Køber L; Vestbo J; Iversen K
    Hemodial Int; 2016 Jan; 20(1):68-77. PubMed ID: 26245152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Validation of the Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI) equation in advanced chronic renal failure.
    Teruel Briones JL; Gomis Couto A; Sabater J; Fernández Lucas M; Rodríguez Mendiola N; Villafruela JJ; Quereda C
    Nefrologia; 2011; 31(6):677-82. PubMed ID: 22130283
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevalence of colorectal adenomatous polyps in patients with chronic obstructive pulmonary disease.
    Chun EM; Kim SW; Lim SY
    Int J Chron Obstruct Pulmon Dis; 2015; 10():955-60. PubMed ID: 26028968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Misidentification of airflow obstruction: prevalence and clinical significance in an epidemiological study.
    Pothirat C; Chaiwong W; Phetsuk N; Liwsrisakun C
    Int J Chron Obstruct Pulmon Dis; 2015; 10():535-40. PubMed ID: 25792821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glomerular filtration rate affects interpretation of pulmonary function test in a Korean general population: results from the Korea National Health and Nutrition Examination Survey 2010 to 2012.
    Kim YS; Kim HY; Ahn HS; Sohn TS; Song JY; Lee YB; Lee DH; Lee JI; Lee TK; Jeong SC; Hong M; Chae HS; Han K; Yeo CD
    Korean J Intern Med; 2016 Nov; 31(6):1101-1109. PubMed ID: 26996347
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A hospital-based study on pulmonary function tests and exercise tolerance in patients of chronic obstructive pulmonary disease and other diseases.
    Majumdar S; Sen S; Mandal SK
    J Indian Med Assoc; 2007 Oct; 105(10):565-6, 568, 570 passim. PubMed ID: 18383952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical profile and management of hypertensive patients with chronic ischemic heart disease and renal dysfunction attended by cardiologists in daily clinical practice.
    Barrios V; Escobar C; Murga N; de Pablo C; Bertomeu V; Calderón A; Echarri R
    J Hypertens; 2008 Nov; 26(11):2230-5. PubMed ID: 18854765
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined effects of lung function, blood gases and kidney function on the exacerbation risk in stable COPD: Results from the COSYCONET cohort.
    Trudzinski FC; Kahnert K; Vogelmeier CF; Alter P; Seiler F; Fähndrich S; Watz H; Welte T; Speer T; Zewinger S; Biertz F; Kauczor HU; Jörres RA; Bals R;
    Respir Med; 2019; 154():18-26. PubMed ID: 31203096
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Three-Year Hospitalization and Mortality in Elderly Smokers with Chronic Obstructive Pulmonary Disease or Chronic Heart Failure.
    Beghé B; Fabbri LM; Garofalo M; Schito M; Verduri A; Bortolotti M; Stendardo M; Ruggieri V; Fucili A; Sverzellati N; Della Casa G; Maietti E; Clini EM; Boschetto P
    Respiration; 2019; 97(3):223-233. PubMed ID: 30205380
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.